NLS Pharmaceutics AG NLSP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
0.53quote price arrow up+0.00 (+0.09%)
Volume
1,266
Close
0.5305quote price arrow down-0.0567 (-9.656%)
Volume
43,710
52 week range
0.46 - 3.72
Loading...
  • Open0.5899
  • Day High0.5899
  • Day Low0.53
  • Prev Close0.5872
  • 52 Week High3.72
  • 52 Week High Date07/15/21
  • 52 Week Low0.46
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap10.06M
  • Shares Out18.97M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-52.21

KEY STATS

  • Open0.5899
  • Day High0.5899
  • Day Low0.53
  • Prev Close0.5872
  • 52 Week High3.72
  • 52 Week High Date07/15/21
  • 52 Week Low0.46
  • 52 Week Low Date06/16/22
  • Market Cap10.06M
  • Shares Out18.97M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-52.21

RATIOS/PROFITABILITY

  • EPS (TTM)-1.00
  • P/E (TTM)-0.53
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-11.851M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NLS Pharmaceutics AG

There is no recent news for this security.

Profile

MORE
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Ronald Hafner
Independent Chairman of the Board
Alexander Zwyer
Chief Executive Officer, Director
Silvia Panigone Ph.D.
Chief Operating Officer
Subhasis Roy
Interim Chief Financial Officer
Address
Alter Postplatz 2
Stans
6370
Switzerland